Article
Molecular genesis of drug-resistant and vaccine-escape HBV mutants.
Antiviral therapy - 1 Jan 2010
Locarnini Stephen A, Yuen Lilly
Abstract excerpt
A high rate of viral turnover, combined with an error-prone polymerase, results in a very high frequency of mutational events during HBV replication. Not surprisingly, particular selection pressures, both endogenous (host immune clearance) and exogenous (vaccines and antivirals), readily select o...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
